Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- MERCURIndependent statistical analysis of A Study of Subcutaneous Mircera in Participants With Chronic Kidney Disease Not Treated With ESA or on Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- MERITIndependent statistical analysis of A Study of Erlotinib (Tarceva) in Participants With Non-Small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MERITIndependent statistical analysis of Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02623426).
- Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection: Complete Statistical AnalysisIndependent statistical analysis of Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00751140).
- MERLINIndependent statistical analysis of A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MERLOTIndependent statistical analysis of Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01006538).
- MERMAID-1Independent statistical analysis of Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate…
- Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC): Complete Statistical AnalysisIndependent statistical analysis of Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Mesalamine to Reduce T Cell Activation in HIV Infection: Complete Statistical AnalysisIndependent statistical analysis of Mesalamine to Reduce T Cell Activation in HIV Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01090102).
- MESHIndependent statistical analysis of Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04135937).
- Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma: Complete Statistical AnalysisIndependent statistical analysis of Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MESRIXIndependent statistical analysis of Mesenchymal Stemcells for Radiation Induced Xerostomia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02513238).
- Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer: Complete Statistical AnalysisIndependent statistical analysis of Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MESTRE-MSIndependent statistical analysis of MEasuring Satisfaction of Treatment With REbif After Initial Treatment of Multiple Sclerosis (MS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- METIndependent statistical analysis of Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MeT1Independent statistical analysis of Effect of Metformin on Vascular and Mitochondrial Function in Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- META-DIndependent statistical analysis of The Effect on Lipid Profile of Switching to Delstrigo in HIV Positive Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Metabolic and Clinical Effect of Alpha-lipoic Acid Administration in Schizophrenic Subjects: Complete Statistical AnalysisIndependent statistical analysis of Metabolic and Clinical Effect of Alpha-lipoic Acid Administration in Schizophrenic Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Metabolic Effects of Non-Thymidine Analogue Anti-HIV Medications: Complete Statistical AnalysisIndependent statistical analysis of Metabolic Effects of Non-Thymidine Analogue Anti-HIV Medications: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00433992).
- Metabolic Parameters 3 Months, 9 Months, and 2 Years After Bariatric Surgery: Complete Statistical AnalysisIndependent statistical analysis of Metabolic Parameters 3 Months, 9 Months, and 2 Years After Bariatric Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients: Complete Statistical AnalysisIndependent statistical analysis of Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03743025).
- Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea: Complete Statistical AnalysisIndependent statistical analysis of Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Metabolism of NNK in Japanese Americans: Complete Statistical AnalysisIndependent statistical analysis of Metabolism of NNK in Japanese Americans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04228952).
- Metabolomics of Insomnia-Related Hyperarousal: Complete Statistical AnalysisIndependent statistical analysis of Metabolomics of Insomnia-Related Hyperarousal: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01957111).
- Metazym for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD): Complete Statistical AnalysisIndependent statistical analysis of Metazym for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- METEORIndependent statistical analysis of A Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Metformin as an Adjunctive Therapy to Catheter Ablation in Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of Metformin as an Adjunctive Therapy to Catheter Ablation in Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia: Complete Statistical AnalysisIndependent statistical analysis of Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus: Complete Statistical AnalysisIndependent statistical analysis of Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery: Complete Statistical AnalysisIndependent statistical analysis of Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01433913).
- Metformin in Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Metformin in Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02252081).
- Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01666730).
- Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00678080).
- Metformin, Muscle Energetics, and Vascular Function in Older Adults With Peripheral Artery Disease: Complete Statistical AnalysisIndependent statistical analysis of Metformin, Muscle Energetics, and Vascular Function in Older Adults With Peripheral Artery Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Methadone vs Magnesium in Spinal Fusion: Complete Statistical AnalysisIndependent statistical analysis of Methadone vs Magnesium in Spinal Fusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01795495).
- Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer: Complete Statistical AnalysisIndependent statistical analysis of Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs: Complete Statistical AnalysisIndependent statistical analysis of Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03077711).
- Methods Project 4: Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Methods Project 4: Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01867242).
- Methohexital v Propofol as General Anesthetic in Patients on ACEIs or ARBs: Complete Statistical AnalysisIndependent statistical analysis of Methohexital v Propofol as General Anesthetic in Patients on ACEIs or ARBs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan): Complete Statistical AnalysisIndependent statistical analysis of Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage: Complete Statistical AnalysisIndependent statistical analysis of Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI): Complete Statistical AnalysisIndependent statistical analysis of Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00453921).
- Methylphenidate Treatment of Attention Deficits in Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of Methylphenidate Treatment of Attention Deficits in Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02178995).
- Metronidazole for Pulmonary Tuberculosis (South Korea): Complete Statistical AnalysisIndependent statistical analysis of Metronidazole for Pulmonary Tuberculosis (South Korea): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00425113).
- MG-1Independent statistical analysis of Open-Label Study for Shoulder Dislocation Using MG-1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01528319).
- MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study: Complete Statistical AnalysisIndependent statistical analysis of MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MGC018 With or Without MGA012 in Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of MGC018 With or Without MGA012 in Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03729596).
- MGPASIndependent statistical analysis of Mentor MemoryGel Post-Approval Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00756652).
- MgPOEMIndependent statistical analysis of Magnesium for Peroral Endoscopic Myotomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04638881).